Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs

Abstract Introduction This open-label study evaluated the immunogenicity, safety, and efficacy of sarilumab monotherapy in patients with active, moderate-to-severe rheumatoid arthritis (RA) and inadequate response or intolerance to prior conventional synthetic disease-modifying antirheumatic drugs....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Alvin F. Wells, Janie Parrino, Erin K. Mangan, Anne Paccaly, Yong Lin, Christine Xu, Chunpeng Fan, Neil M. H. Graham, Hubert van Hoogstraten, Albert Torri
Formato: Artigo
Idioma:Inglês
Publicado em: Adis, Springer Healthcare 2019-05-01
Colecção:Rheumatology and Therapy
Assuntos:
Arthritis
Biological DMARDs
Rheumatoid arthritis
Acesso em linha:http://link.springer.com/article/10.1007/s40744-019-0157-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados